Who we are

The Patvocates Network is both a patient-driven think tank and patient-focused consultancy in the triangle of patient advocacy, health policy and social media.

The Patvocates Network is run by activists with decades of experience in patient advocacy. We provide valuable advice, insights, experiences and connections in supporting patient engagement strategy development, stakeholder identification, system readiness and project implementation in patient organisations and other stakeholders engaging with them - regulators, ethics committees, academic institutions and organisations and the pharmaceutical industry. We focus on strengthening patient advocates activities on multiple levels: supporting patients and peers, influencing health policy, and collaborating with stakeholders in research and development. > Read more about what we do

The Patvocates Network is registered in Germany and acting mainly on a European level.


The core team of the Patvocates Network:

Jan Geissler

Jan Geissler

Jan Geissler is founder and managing director of Patvocates, acting as advisor on patient advocacy, health policy and social media. For the past 15 years, Jan has engaged in patient advocacy on the European and international level, based on his experience as both a cancer survivor, advocate and a patient expert. He has founded LeukaNET and a has co-founded the CML Advocates Network, the Leukemia Patient Advocates Foundation, the Workgroup of European Cancer patient Advocacy Networks (WECAN) as well as the European Cancer Patient Coalition. From 2011-2017, Jan has been working for the European Patients' Forum as the Director of  the European Patients' Academy (EUPATI). He is acting as advisor in a number of advisory boards, committees and expert groups, e.g. of the European Commission, medical societies, medical journals and the pharmaceutical industry.

Read more about Jan here.

David Haerry

David U. Haerry

David Haerry has been a treatment writer and reporting to patients and lay people from scientific conferences since 1996. He has a long standing experience in collaborating with industry and academic researchers on drug development, planning pivotal and academic studies at global level and taking the patient voice to cohort studies and patient registries. He is collaborating intensively with the European Medicines Agency EMA since 2005 and with Swissmedic since 2014. From 2014 to 2016, he was a member of the working group revising the CIOMS International Ethical Guidelines for Health-related Research involving Humans.

Read more about David here

Tamas Bereczky

Tamás Bereczky

Tamás currently works as the communications advisor of the European AIDS Treatment Group (www.eatg.org), the largest European network of individuals living with HIV. HIV positive since 2003, he served as a member of the board of directors of the EATG for almost 4 years, and also served the co-chair of the European Commission’s Civil Society Forum on HIV/AIDS between 2013 and 2015. Tamás speaks German, English and Hungarian. He is father to an adult daughter and lives with his partner in Budapest, Hungary.

Read more about Tamás here

Comments are closed